SynRx Therapeutics
Yuhang
About SynRx Therapeutics
SynRx Therapeutics produces medicines for cancer and concentrates on the development of novel drugs targeting the DNA damage repair pathway. They provide therapies for the patients fighting against cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: synrx-therapeutics.comenindex.html
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/synrx-therapeutics-28352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.